H. Riera, A. Barbara; F. Aprile; E. Maheu; D. Mitrovic, [Effect of oxaceprol on the synthesis and degradation in vitro of proteoglycans and proteins by calf articular cartilage explants]., in Rev Rhum Mal Osteoartic, vol. 57, n. 7-8, pp. 579-83, PMID 2281302.
H. Riera, F. Aprile; D. Mitrovic, [Effect of oxaceprol on the structure of proteoglycans synthesized by articular chondrocytes from calves]., in Rev Rhum Mal Osteoartic, vol. 58, n. 9, Oct 1991, pp. 629-34, PMID 1775913.
K. Krüger, M. Klasser; J. Mössinger; U. Becker, Oxaceprol--a randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug., in Clin Exp Rheumatol, vol. 25, n. 1, pp. 29-34, PMID 17417987.
MJ. Parnham, Antirheumatic agents and leukocyte recruitment. New light on the mechanism of action of oxaceprol., in Biochem Pharmacol, vol. 58, n. 2, Jul 1999, pp. 209-15, PMID 10423160.
G. Lachmann, B. Siegemund; W. Kusche, Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administration., in Arzneimittelforschung, vol. 40, 2 Pt 1, Feb 1990, pp. 200-6, PMID 2334462.
C. Famulari, M. Monaco; A. Versaci; S. Perri; ML. Terranova; D. Cuzzocrea, [Action of N-acetyl-hydroxyproline in the treatment of cutaneous ulcerative lesions]., in Ann Ital Chir, vol. 51, n. 5, 1979, pp. 527-36, PMID 555265.
HW. Bauer, M. Klasser; KL. von Hanstein; H. Rolinger; G. Schladitz; HD. Henke; W. Gimbel; K. Steinbach, Oxaceprol is as effective as diclofenac in the therapy of osteoarthritis of the knee and hip., in Clin Rheumatol, vol. 18, n. 1, 1999, pp. 4-9, PMID 10088941.
G. Herrmann, D. Steeger; M. Klasser; J. Wirbitzky; M. Fürst; R. Venbrocks; H. Rohde; D. Jungmichel; HD. Hildebrandt; MJ. Parnham; W. Gimbel, Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac., in Clin Rheumatol, vol. 19, n. 2, 2000, pp. 99-104, PMID 10791619.